S. Grant

Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.

N. Freemantle, Y. Rosenberg, D. Wyse, 2011, Journal of the American College of Cardiology.

Postextrasystolic U wave augmentation, a new marker of increased arrhythmic risk in patients without the long QT syndrome.

J. Olgin, M. Lesh, H. Barron, 1996, Journal of the American College of Cardiology.